SCHEMBL19845149

SCHEMBL19845149

CC(C)n1c2ccccc2c2cc3c(cc21)-c1ccccc1C3(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ NPY5R Q15761 5/20 0.39
▸ BCHE P06276 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ MAPT P10636 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ RORC P51449 2/20 0.34
▸ RORA P35398 1/20 0.34
▸ RORB Q92753 1/20 0.34
▸ CHEK1 O14757 1/20 0.33
▸ WEE1 P30291 1/20 0.33
▸ POLB P06746 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19845146 0.94 MEN1 (0.47) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL19845121 0.85 MEN1 (0.47) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL17773993 0.82 MEN1 (0.38) MEN1KMT2ANPY5RRORCRORA
SCHEMBL2609836 0.81 GPR3 (0.48) MEN1KMT2ANPY5RMAPTTSHR
SCHEMBL14148335 0.81 MLNR (0.32) HPGDKDM4EALDH1A1GAA
SCHEMBL19845128 0.81 MEN1 (0.41) MEN1KMT2ANPY5RRORCRORA
SCHEMBL25059079 0.80 MAPT (0.35) MEN1KMT2AMAPTMAPK1TDP1
SCHEMBL25679007 0.80 MAPT (0.32) MEN1KMT2AMAPTMAPK1TDP1
SCHEMBL19845141 0.80 MEN1 (0.42) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL17245623 0.79 KDM4E (0.43) MEN1KMT2AMAPTMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-02-08 — — US disclosed
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-02-08 — — US disclosed
US-20150376120-A1 ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS Technische Universität Berlin (DE) 2015-12-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE PIEZO1, ETV6, LEF1 MEN1 435/4885KMT2A 1872/4885NPY5R 3238/4885
US-20150376120-A1 ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS MB, ALB, BCAT2 MEN1 2301/4885KMT2A 4398/4885NPY5R 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback